Work

Split First Dose Administration of Daratumumab for the Treatment of Patients with Multiple Myeloma (MM): Clinical Pharmacology and Population Pharmacokinetic (PK) Analyses

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-113171

Authors: Xu Steven Xu, Philippe Moreau, Saad Z. Usmani, Sagar Lonial, Andrzej Jakubowiak, Albert Oriol, Amrita Krishnan, Joan Bladé, Melody Luo, Yu-Nien Sun, Liping Zhang, William Deraedt, Ming Qi, Jon Ukropec, Pamela L Clemens

Institutions: Janssen Research & Development (United States), Centre Hospitalier Universitaire de Nantes, Nantes Université, Levine Cancer Institute, Emory University, Winship Cancer Institute, University of Chicago Medical Center, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, City Of Hope National Medical Center, City of Hope, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Janssen (Belgium), Janssen Scientific Affairs (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2904733388

Cites:

Cited by: 2

Related to: 10